CochLear Operating Income 2023-2025 | CHEOY
CochLear annual/quarterly operating income history and growth rate from 2023 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- CochLear operating income for the quarter ending June 30, 2025 was $0M, a 0% increase year-over-year.
- CochLear operating income for the twelve months ending June 30, 2025 was $0M, a 0% increase year-over-year.
- CochLear annual operating income for 2025 was $0.335B, a 7.65% increase from 2024.
- CochLear annual operating income for 2024 was $0.312B, a 18.8% increase from 2023.
- CochLear annual operating income for 2023 was $0.262B, a 9.64% decline from 2022.
|
CochLear Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $335 |
| 2024 | $312 |
| 2023 | $262 |
| 2022 | $290 |
| 2021 | $1,153 |
| 2020 | $887 |
| 2019 | $1,020 |
| 2018 | $1,057 |
| 2017 | $945 |
| 2016 | $824 |
|
CochLear Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | |
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.666B | $1.525B |
| Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $168.818B | 31.00 |
| HCA Healthcare (HCA) | United States | $108.237B | 17.92 |
| CVS Health (CVS) | United States | $102.012B | 11.73 |
| Elevance Health (ELV) | United States | $83.333B | 12.22 |
| Cencora (COR) | United States | $66.377B | 21.40 |
| Natera (NTRA) | United States | $32.568B | 0.00 |
| DiDi Global (DIDIY) | China | $23.956B | 22.13 |
| Labcorp Holdings (LH) | United States | $20.757B | 15.83 |
| Medpace Holdings (MEDP) | United States | $16.879B | 41.90 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.455B | 0.00 |
| BioMerieux (BMXMF) | France | $15.505B | 0.00 |
| Solventum (SOLV) | United States | $14.863B | 14.43 |
| Viatris (VTRS) | United States | $14.604B | 5.44 |
| ICON (ICLR) | Ireland | $14.548B | 14.44 |
| Revvity (RVTY) | United States | $11.779B | 21.69 |
| Charles River Laboratories (CRL) | United States | $10.769B | 20.74 |
| Avantor (AVTR) | United States | $8.373B | 12.79 |
| Sonic Healthcare (SKHHY) | Australia | $7.695B | 0.00 |
| HealthEquity (HQY) | United States | $7.224B | 27.02 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.223B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.036B | 41.95 |
| PACS (PACS) | United States | $6.501B | 39.53 |
| Bausch + Lomb (BLCO) | Canada | $6.199B | 40.70 |
| Sotera Health (SHC) | United States | $5.395B | 26.01 |
| Alignment Healthcare (ALHC) | United States | $4.258B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.447B | 60.53 |
| Concentras Parent (CON) | United States | $2.642B | 16.49 |
| Progyny (PGNY) | United States | $2.450B | 48.17 |
| Organon (OGN) | United States | $2.111B | 2.22 |
| Surgery Partners (SGRY) | United States | $2.106B | 27.13 |
| Pediatrix Medical (MD) | United States | $1.946B | 11.62 |
| Establishment Labs Holdings (ESTA) | United States | $1.940B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.287B | 0.00 |
| Nutex Health (NUTX) | United States | $1.278B | 9.77 |
| Ardent Health (ARDT) | United States | $1.269B | 4.14 |
| CareDx (CDNA) | United States | $1.058B | 17.29 |
| GoodRx Holdings (GDRX) | United States | $0.978B | 16.00 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| Embecta (EMBC) | United States | $0.761B | 4.33 |
| InnovAge Holding (INNV) | United States | $0.754B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.672B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.602B | 0.00 |
| CryoPort (CYRX) | United States | $0.533B | 0.00 |
| Enhabit (EHAB) | United States | $0.516B | 23.16 |
| Strata Critical Medical (SRTA) | United States | $0.500B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.459B | 8.43 |
| Agilon Health (AGL) | United States | $0.409B | 0.00 |
| Oncology Institute (TOI) | United States | $0.379B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.358B | 75.29 |
| Auna S.A (AUNA) | Luxembourg | $0.355B | 5.70 |
| Shoulder Innovations (SI) | United States | $0.292B | 0.00 |
| So-Young (SY) | China | $0.278B | 0.00 |
| KindlyMD (NAKA) | United States | $0.203B | 0.00 |
| LifeMD (LFMD) | United States | $0.202B | 0.00 |
| Beauty Health (SKIN) | United States | $0.193B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.144B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.088B | 0.00 |
| Biodesix (BDSX) | United States | $0.064B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Pomdoctor - (POM) | China | $0.032B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.24 |
| Intelligent Bio Solutions (INBS) | United States | $0.019B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |